<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oncology Product Guide &#187; Radient Pharmaceuticals Corporation</title>
	<atom:link href="http://www.oncologyproductguide.com/blog/tag/radient-pharmaceuticals-corporation/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.oncologyproductguide.com/blog</link>
	<description>A comprehensive guide to oncology products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 12:00:01 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Radient Pharmaceuticals Expands Distribution Partnership With GenWay Biotech to Penetrate Highly Strategic International Markets With Its Onko-Sure Cancer Test</title>
		<link>http://www.oncologyproductguide.com/blog/2009/12/24/radient-pharmaceuticals-expands-distribution-partnership-with-genway-biotech-to-penetrate-highly-strategic-international-markets-with-its-onko-sure-cancer-test/</link>
		<comments>http://www.oncologyproductguide.com/blog/2009/12/24/radient-pharmaceuticals-expands-distribution-partnership-with-genway-biotech-to-penetrate-highly-strategic-international-markets-with-its-onko-sure-cancer-test/#comments</comments>
		<pubDate>Thu, 24 Dec 2009 05:29:39 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Treatments]]></category>
		<category><![CDATA[GenWay Biotech Inc]]></category>
		<category><![CDATA[Onko-Sure(TM)]]></category>
		<category><![CDATA[Radient Pharmaceuticals Corporation]]></category>
		<category><![CDATA[vitro diagnostic cancer]]></category>

		<guid isPermaLink="false">http://www.oncologyproductguide.com/blog/?p=194</guid>
		<description><![CDATA[Radient Pharmaceuticals Corporation (RPC) has announced that it has signed a 3-year marketing, sales and distribution agreement with GenWay Biotech Inc. Under the terms of the agreement, GenWay Biotech Inc. has non-exclusive rights to distribute RPC&#8217;s Onko-Sure(TM) in vitro diagnostic cancer (IVD) test in the European Union, Middle East (excluding Israel), United Kingdom and Russia; [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/12/Radient-Pharmaceuticals-Corporation.png"><img class="alignleft size-full wp-image-195" style="margin: 5px" src="http://www.oncologyproductguide.com/blog/wp-content/uploads/2009/12/Radient-Pharmaceuticals-Corporation.png" border="0" alt="Radient Pharmaceuticals Corporation" width="200" height="30" /></a>Radient Pharmaceuticals Corporation (RPC) has announced that it has signed a 3-year marketing, sales and distribution agreement with GenWay Biotech Inc. Under the terms of the agreement, GenWay Biotech Inc. has non-exclusive rights to distribute RPC&#8217;s Onko-Sure(TM) in vitro diagnostic cancer (IVD) test in the European Union, Middle East (excluding Israel), United Kingdom and Russia; and is responsible for product sales and marketing in these markets.</p>
<p>For the full story, <a href="http://money.cnn.com/news/newsfeeds/articles/marketwire/0571265.htm" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.oncologyproductguide.com/blog/2009/12/24/radient-pharmaceuticals-expands-distribution-partnership-with-genway-biotech-to-penetrate-highly-strategic-international-markets-with-its-onko-sure-cancer-test/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
